
Becton, Dickinson and Company: shareholders and insiders
Price
$216.47
November 16, 2026Market cap $61.8B
What Ploutos Investor adds for Becton, Dickinson and Company
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from FY2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has risen 23% since Aug 6, 2026, when the 10-Q these figures come from was filed ($177.07 then, $217.75 on Nov 16, 2026). The figures date from before that move.10-Q
- The latest annual figures the company filed are for 2025, more than a year ago. Newer ones may be late.
Insiders and their shares
Purchases and sales by officers and directors, from their own Form 4 filings.
Reading the newest filings from the SEC. This part fills in on its own in a few seconds.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Vanguard Capital ManagementShare of class7.51%
- State StreetShare of class5.40%
- Vanguard Portfolio ManagementShare of class5.40%
- First Eagle Investment Management, LLCCommonShare of class5.10%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 7.51% | 21.40M | Apr 29, 2026 | 13G | |
| State Street | 5.40% | 15.01M | Aug 7, 2026 | 13G | |
| Vanguard Portfolio Management | 5.40% | 15.39M | Apr 29, 2026 | 13G | |
| First Eagle Investment Management, LLCCommon | 5.10% | 14.14M | Aug 6, 2026 | 13G |
Fell to 5% or less (2)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Starboard ValueIn the quarter
- AQR CapitalIn the quarter-14%
- Millennium Mgmt (Englander)In the quarter
- Bridgewater (Dalio)In the quarter-1.2%
- Citadel Advisors (Griffin)In the quarter-86%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Starboard Value | – | – | 2.19% | |
| AQR Capital | 650.2K | -14% | $98M | 0.03% |
| Millennium Mgmt (Englander) | – | – | 0.02% | |
| Bridgewater (Dalio) | 9,382 | -1.2% | $1.4M | 0.01% |
| Citadel Advisors (Griffin) | 118.8K | -86% | $18M | 0.01% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 3.12% of its shares outstanding were held short, -8.9% since the report before.
- Shares held short
- 8.91M
- 3.12%
- Since the report before9.78M on Sep 30, 2026
- -8.9%
- 5.5
- 1.62M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 66%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 2.27M
- Nov 15, 2023: Shares held short 2.99M
- Nov 30, 2023: Shares held short 2.62M
- Dec 15, 2023: Shares held short 2.43M
- Dec 29, 2023: Shares held short 2.05M
- Jan 12, 2024: Shares held short 2.26M
- Jan 31, 2024: Shares held short 2.46M
- Feb 15, 2024: Shares held short 2.47M
- Feb 29, 2024: Shares held short 2.09M
- Mar 15, 2024: Shares held short 2.79M
- Mar 28, 2024: Shares held short 2.93M
- Apr 15, 2024: Shares held short 2.31M
- Apr 30, 2024: Shares held short 2.17M
- May 15, 2024: Shares held short 1.97M
- May 31, 2024: Shares held short 2.23M
- Jun 14, 2024: Shares held short 1.97M
- Jun 28, 2024: Shares held short 2.32M
- Jul 15, 2024: Shares held short 2.16M
- Jul 31, 2024: Shares held short 1.98M
- Aug 15, 2024: Shares held short 1.48M
- Aug 30, 2024: Shares held short 1.98M
- Sep 13, 2024: Shares held short 2.73M
- Sep 30, 2024: Shares held short 2.48M
- Oct 15, 2024: Shares held short 2.41M
- Oct 31, 2024: Shares held short 2.04M
- Nov 15, 2024: Shares held short 2.11M
- Nov 29, 2024: Shares held short 1.90M
- Dec 13, 2024: Shares held short 2.63M
- Dec 31, 2024: Shares held short 3.73M
- Jan 15, 2025: Shares held short 3.46M
- Jan 31, 2025: Shares held short 2.70M
- Feb 14, 2025: Shares held short 3.72M
- Feb 28, 2025: Shares held short 2.94M
- Mar 14, 2025: Shares held short 2.87M
- Mar 31, 2025: Shares held short 3.79M
- Apr 15, 2025: Shares held short 4.07M
- Apr 30, 2025: Shares held short 3.64M
- May 15, 2025: Shares held short 3.26M
- May 30, 2025: Shares held short 3.15M
- Jun 13, 2025: Shares held short 3.21M
- Jun 30, 2025: Shares held short 3.90M
- Jul 15, 2025: Shares held short 4.69M
- Jul 31, 2025: Shares held short 5.48M
- Aug 15, 2025: Shares held short 5.18M
- Aug 29, 2025: Shares held short 4.56M
- Sep 15, 2025: Shares held short 4.28M
- Sep 30, 2025: Shares held short 3.83M
- Oct 15, 2025: Shares held short 3.28M
- Oct 31, 2025: Shares held short 3.11M
- Nov 14, 2025: Shares held short 4.18M
- Nov 28, 2025: Shares held short 4.79M
- Dec 15, 2025: Shares held short 4.81M
- Dec 31, 2025: Shares held short 6.03M
- Jan 15, 2026: Shares held short 6.07M
- Jan 30, 2026: Shares held short 6.69M
- Feb 13, 2026: Shares held short 14.56M
- Feb 27, 2026: Shares held short 13.78M
- Mar 13, 2026: Shares held short 11.47M
- Mar 31, 2026: Shares held short 9.49M
- Apr 15, 2026: Shares held short 7.21M
- Apr 30, 2026: Shares held short 6.38M
- May 15, 2026: Shares held short 8.41M
- May 29, 2026: Shares held short 7.20M
- Jun 15, 2026: Shares held short 7.28M
- Jun 30, 2026: Shares held short 11.24M
- Jul 15, 2026: Shares held short 10.38M
- Jul 31, 2026: Shares held short 10.02M
- Aug 14, 2026: Shares held short 9.37M
- Aug 31, 2026: Shares held short 10.67M
- Sep 15, 2026: Shares held short 11.32M
- Sep 30, 2026: Shares held short 9.78M
- Oct 15, 2026: Shares held short 8.91M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading41.0% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 41.0% of the shares in the reported trades were short sales, against 39.7% in the 14 before.
- Last 14 sessionsOct 28, 2026 – Nov 16, 2026
- 41.0%
- The 14 beforeOct 8, 2026 – Oct 27, 2026
- 39.7%
- Change
- +1.3 pts
- Short sales a dayon average, of 900.1K shares
- 368.8K
- More than atof 3,668 US-listed companies, same days
- 22%
- Median of alleight in ten from 34.7% to 63.8%
- 50.3%
- Short sales
- Oct 8, 2026: Short sales 45.2%
- Oct 9, 2026: Short sales 38.9%
- Oct 12, 2026: Short sales 36.6%
- Oct 13, 2026: Short sales 45.7%
- Oct 14, 2026: Short sales 37.7%
- Oct 15, 2026: Short sales 30.7%
- Oct 16, 2026: Short sales 49.5%
- Oct 19, 2026: Short sales 41.2%
- Oct 20, 2026: Short sales 34.8%
- Oct 21, 2026: Short sales 54.5%
- Oct 22, 2026: Short sales 49.8%
- Oct 23, 2026: Short sales 41.8%
- Oct 26, 2026: Short sales 29.7%
- Oct 27, 2026: Short sales 31.4%
- Oct 28, 2026: Short sales 20.8%
- Oct 29, 2026: Short sales 40.3%
- Oct 30, 2026: Short sales 43.3%
- Nov 2, 2026: Short sales 29%
- Nov 3, 2026: Short sales 31.7%
- Nov 4, 2026: Short sales 36.5%
- Nov 5, 2026: Short sales 42.7%
- Nov 6, 2026: Short sales 47.9%
- Nov 9, 2026: Short sales 36%
- Nov 10, 2026: Short sales 50.1%
- Nov 11, 2026: Short sales 46.7%
- Nov 12, 2026: Short sales 57.2%
- Nov 13, 2026: Short sales 56.1%
- Nov 16, 2026: Short sales 47.8%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
10b5-1 trading plans
Since 2023 every 10-Q and 10-K says which insiders adopted or ended a trading plan (Rule 10b5-1) in the quarter: when, for how many shares, until when. A plan explains the sales that follow months before they show up on Form 4.
- Michael FeldExecutive Vice President and Chief Revenue Officer of BDWhat happenedAdoptedMay 27, 2026Shares–
- Shana NealExecutive Vice President and Chief People Officer of BDWhat happenedAdoptedFeb 27, 2026Shares4,500
- Michael GarrisonExecutive Vice President and President, Medical Essentials and BioPharma Systems Segments of BDWhat happenedAdoptedFeb 18, 2026Shares2,200
- Michael GarrisonExecutive Vice President and President, Medical SegmentWhat happenedAdoptedAug 13, 2025Shares–
- Thomas E. PolenChairman, Chief Executive Officer and President of BDWhat happenedAdoptedAug 13, 2025Shares47.7K
- Shana NealExecutive Vice President and Chief People OfficerWhat happenedAdoptedFeb 12, 2025Shares–
- Christopher DelOreficeExecutive Vice President and Chief Financial OfficerWhat happenedAdoptedFeb 7, 2025Shares–
- Michael FeldExecutive Vice President and President, Life Sciences SegmentWhat happenedAdoptedFeb 7, 2025Shares–
- Antoine EzellExecutive Vice President, President of the Americas and Chief Marketing OfficerWhat happenedAdoptedDec 16, 2024Shares–
- Richard ByrdExecutive Vice President and President, Interventional Segment of BDWhat happenedAdoptedDec 11, 2024Shares–
| Person | What happened | Until | Shares | Filing |
|---|---|---|---|---|
| Michael FeldExecutive Vice President and Chief Revenue Officer of BD | AdoptedMay 27, 2026 | 445 days | – | 10-Q |
| Shana NealExecutive Vice President and Chief People Officer of BD | AdoptedFeb 27, 2026 | Jun 7, 2027 | 4,500 | 10-Q |
| Michael GarrisonExecutive Vice President and President, Medical Essentials and BioPharma Systems Segments of BD | AdoptedFeb 18, 2026 | Jun 10, 2027 | 2,200 | 10-Q |
| Michael GarrisonExecutive Vice President and President, Medical Segment | AdoptedAug 13, 2025 | 477 days | – | 10-K |
| Thomas E. PolenChairman, Chief Executive Officer and President of BD | AdoptedAug 13, 2025 | 475 days | 47.7K | 10-K |
| Shana NealExecutive Vice President and Chief People Officer | AdoptedFeb 12, 2025 | May 15, 2026 | – | 10-Q |
| Christopher DelOreficeExecutive Vice President and Chief Financial Officer | AdoptedFeb 7, 2025 | May 11, 2026 | – | 10-Q |
| Michael FeldExecutive Vice President and President, Life Sciences Segment | AdoptedFeb 7, 2025 | Aug 20, 2026 | – | 10-Q |
| Antoine EzellExecutive Vice President, President of the Americas and Chief Marketing Officer | AdoptedDec 16, 2024 | Mar 17, 2026 | – | 10-Q |
| Richard ByrdExecutive Vice President and President, Interventional Segment of BD | AdoptedDec 11, 2024 | Mar 15, 2026 | – | 10-Q |
As the company states them in Item 9B of the 10-K and Part II, Item 5 of the 10-Q, with structured data. A plan allows sales on preset dates and prices. It does not say whether all of them will be executed.
Executive pay
From the Pay versus Performance table every company puts in its proxy statement since 2023: what the chief executive was paid, what was actually paid once the shares vest at year-end values, and how the stock did against the peer group the company itself picked.
$17M
Actually paid: $3.5M
$4.3M
Actually paid: $2.2M
$89
Peers: $130
Revenue
$21.8B
From the proxy statement (DEF 14A) of Dec 18, 2025, as filed with the SEC with structured data. Pay in dollars. The company picks its own peer group and measure. DEF 14A
Share repurchases
How many of its own shares the company bought each quarter, at what average price, for how much, and what remains of the program its board authorized, from the table it puts in every 10-Q and 10-K.
- Mar 31, 202610-QAmount$1.6B
- Dec 31, 202510-QAmount$250M
- Sep 30, 202510-KAmount$250M
- Dec 31, 202410-QAmount$608M
- Dec 31, 202310-QAmount$500M
- Sep 30, 202210-KAmount$500M
- Sep 30, 202110-KAmount$732M
| Quarter | Shares | Average price | Amount | Left in the program | Filing |
|---|---|---|---|---|---|
| Mar 31, 202610-Q | 9.32M | $171.69 | $1.6B | 11.51M shares | 10-Q |
| Dec 31, 202510-Q | 1.32M | $190.07 | $250M | 10.83M shares | 10-Q |
| Sep 30, 202510-K | 1.28M | $195.66 | $250M | 12.15M shares | 10-K |
| Dec 31, 202410-Q | 2.64M | $230.37 | $608M | 4.05M shares | 10-Q |
| Dec 31, 202310-Q | 2.12M | $236.06 | $500M | 6.68M shares | 10-Q |
| Sep 30, 202210-K | 1.95M | $256.00 | $500M | 8.80M shares | 10-K |
| Sep 30, 202110-K | 2.92M | $250.61 | $732M | 1.22M shares | 10-K |
From the "Issuer Purchases of Equity Securities" table of the 10-Qs and 10-Ks, read without a model. Only the quarters whose shares times average price agree with the cash the company says it paid for repurchases in its cash-flow statement are shown. The shares include those withheld for officers' taxes. A quarter with an accelerated repurchase shows the table's shares and the cash paid, without an average price. 16 filing(s) not shown, as the table was not read or did not agree with the cash.
The shareholders' vote on pay
The advisory say-on-pay vote at each annual meeting, as the company states it in the 8-K it files after the meeting: how many voted for and against the executives' pay. 90% is the norm. Under 70% proxy advisers expect the board to respond the next year.
- 2026Jan 30, 2026For91.4%
- 2025Jan 31, 2025For89.0%
- 2024Jan 26, 2024For92.6%
- 2023Jan 30, 2023For92.9%
- 2022Jan 26, 2022For78.9%
- 2021Jan 28, 2021For67.0%
| Year | For | Votes for | Votes against | Abstentions | Broker non-votes | Filing |
|---|---|---|---|---|---|---|
| 2026Jan 30, 2026 | 91.4% | 220M | 20.66M | 1.18M | 16.71M | 8-K |
| 2025Jan 31, 2025 | 89.0% | 208M | 25.70M | 622.8K | 21.17M | 8-K |
| 2024Jan 26, 2024 | 92.6% | 221M | 17.67M | 1.65M | 19.25M | 8-K |
| 2023Jan 30, 2023 | 92.9% | 218M | 16.61M | 773.9K | 19.06M | 8-K |
| 2022Jan 26, 2022 | 78.9% | 183M | 48.90M | 573.5K | 18.41M | 8-K |
| 2021Jan 28, 2021 | 67.0% | 155M | 76.27M | 1.14M | 20.73M | 8-K |
From the 8-K (item 5.07) the company files after each annual meeting since 2021, read from the filing's text without a model. A company that votes every three years has empty years. The vote is advisory: the board is not bound by it.
The ETFs that hold it
Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IHIiShares U.S. Medical Devices ETFWeight in the fund4.63%
- NOBLProShares S&P 500 Dividend Aristocrats ETFWeight in the fund1.73%
- COWZPacer US Cash Cows 100 ETFWeight in the fund1.01%
- IYHiShares U.S. Healthcare ETFWeight in the fund0.78%
- VHTVanguard Health Care Index FundWeight in the fund0.74%
- XLVState Street(R) Health Care Select Sector SPDR(R) ETFWeight in the fund0.73%
- VOEVanguard Mid-Cap Value Index FundWeight in the fund0.72%
- IXJiShares Global Healthcare ETFWeight in the fund0.54%
- IWSiShares Russell Mid-Cap Value ETFWeight in the fund0.42%
- VOVanguard Mid-Cap Index FundWeight in the fund0.40%
43 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 1,486
- Q4 2025: Managers 1,552
- Q1 2026: Managers 1,479
- Q2 2026: Managers 1,437
Institutional investors by quarter
The fund managers holding BDX, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 1,437 managers held 278M shares, worth $43.3B. During the quarter 137 opened a position, 179 closed one, 539 added and 538 trimmed.
The largest holders, Q2 2026
- First Eagle Investment ManagementIn the quarter+132%
- BlackRockIn the quarter-6.0%
- Vanguard Capital ManagementIn the quarter-2.7%
- State StreetIn the quarter+8.5%
- Vanguard Portfolio ManagementIn the quarter-2.2%
- InvescoIn the quarter-13%
- Massachusetts Financial ServicesIn the quarter-4.9%
- Geode Capital ManagementIn the quarter+15%
- Franklin ResourcesIn the quarter+31%
- Wellington Management GroupIn the quarter-3.9%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| First Eagle Investment Management | 27.63M | +132% | $4.2B |
| BlackRock | 24.59M | -6.0% | $3.7B |
| Vanguard Capital Management | 17.99M | -2.7% | $2.7B |
| State Street | 15.00M | +8.5% | $2.3B |
| Vanguard Portfolio Management | 14.97M | -2.2% | $2.3B |
| Invesco | 8.90M | -13% | $1.3B |
| Massachusetts Financial Services | 8.65M | -4.9% | $2.5B |
| Geode Capital Management | 8.14M | +15% | $1.2B |
| Franklin Resources | 7.01M | +31% | $1.1B |
| Wellington Management Group | 6.36M | -3.9% | $962M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
The full analysis
What do Becton, Dickinson and Company's filings show?
Who buys and sells is one part of Becton, Dickinson and Company's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Which well-known managers hold BDX?
5 of the managers we track held the shares on Jun 30, 2026. The largest position was AQR Capital's, worth $98M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.